vs

Side-by-side financial comparison of Cooper Companies (The) (COO) and Symbotic Inc. (SYM). Click either name above to swap in a different company.

Cooper Companies (The) is the larger business by last-quarter revenue ($1.1B vs $630.0M, roughly 1.7× Symbotic Inc.). Cooper Companies (The) runs the higher net margin — 7.9% vs 0.4%, a 7.5% gap on every dollar of revenue. On growth, Symbotic Inc. posted the faster year-over-year revenue change (29.4% vs 4.6%). Over the past eight quarters, Symbotic Inc.'s revenue compounded faster (21.9% CAGR vs 6.9%).

The Cooper Companies, Inc., branded as CooperCompanies, is a global medical device company headquartered in San Ramon, California. The company consists of two business units, CooperVision (CVI) which manufactures contact lenses, and CooperSurgical (CSI), which manufactures medical devices and fertility and genomic products for the women's healthcare market.

Symbotic Inc. is an American robotics warehouse automation company based in Wilmington, Massachusetts.

COO vs SYM — Head-to-Head

Bigger by revenue
COO
COO
1.7× larger
COO
$1.1B
$630.0M
SYM
Growing faster (revenue YoY)
SYM
SYM
+24.9% gap
SYM
29.4%
4.6%
COO
Higher net margin
COO
COO
7.5% more per $
COO
7.9%
0.4%
SYM
Faster 2-yr revenue CAGR
SYM
SYM
Annualised
SYM
21.9%
6.9%
COO

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
COO
COO
SYM
SYM
Revenue
$1.1B
$630.0M
Net Profit
$84.6M
$2.6M
Gross Margin
61.1%
21.2%
Operating Margin
13.2%
1.0%
Net Margin
7.9%
0.4%
Revenue YoY
4.6%
29.4%
Net Profit YoY
-28.0%
174.9%
EPS (diluted)
$0.42
$0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
COO
COO
SYM
SYM
Q4 25
$1.1B
$630.0M
Q3 25
$1.1B
$618.5M
Q2 25
$1.0B
$592.1M
Q1 25
$964.7M
$549.7M
Q4 24
$1.0B
$486.7M
Q3 24
$1.0B
$503.6M
Q2 24
$942.6M
$491.9M
Q1 24
$931.6M
$424.3M
Net Profit
COO
COO
SYM
SYM
Q4 25
$84.6M
$2.6M
Q3 25
$98.3M
$-3.6M
Q2 25
$87.7M
$-5.9M
Q1 25
$104.3M
$-3.9M
Q4 24
$117.5M
$-3.5M
Q3 24
$104.7M
$-2.5M
Q2 24
$88.9M
$-2.5M
Q1 24
$81.2M
$-6.6M
Gross Margin
COO
COO
SYM
SYM
Q4 25
61.1%
21.2%
Q3 25
65.3%
20.6%
Q2 25
67.8%
18.2%
Q1 25
68.4%
19.6%
Q4 24
66.5%
16.4%
Q3 24
66.1%
12.7%
Q2 24
67.0%
13.7%
Q1 24
67.0%
10.4%
Operating Margin
COO
COO
SYM
SYM
Q4 25
13.2%
1.0%
Q3 25
16.6%
-3.5%
Q2 25
18.4%
-6.2%
Q1 25
18.9%
-5.8%
Q4 24
19.5%
-5.1%
Q3 24
19.2%
-4.3%
Q2 24
17.2%
-5.1%
Q1 24
16.4%
-12.0%
Net Margin
COO
COO
SYM
SYM
Q4 25
7.9%
0.4%
Q3 25
9.3%
-0.6%
Q2 25
8.7%
-1.0%
Q1 25
10.8%
-0.7%
Q4 24
11.5%
-0.7%
Q3 24
10.4%
-0.5%
Q2 24
9.4%
-0.5%
Q1 24
8.7%
-1.6%
EPS (diluted)
COO
COO
SYM
SYM
Q4 25
$0.42
$0.02
Q3 25
$0.49
$-0.04
Q2 25
$0.44
$-0.05
Q1 25
$0.52
$-0.04
Q4 24
$0.59
$-0.03
Q3 24
$0.52
$-0.03
Q2 24
$0.44
$-0.02
Q1 24
$0.41
$-0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
COO
COO
SYM
SYM
Cash + ST InvestmentsLiquidity on hand
$110.6M
$1.8B
Total DebtLower is stronger
$2.5B
Stockholders' EquityBook value
$8.2B
$663.8M
Total Assets
$12.4B
$3.0B
Debt / EquityLower = less leverage
0.30×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
COO
COO
SYM
SYM
Q4 25
$110.6M
$1.8B
Q3 25
$124.9M
$1.2B
Q2 25
$116.2M
$777.6M
Q1 25
$100.9M
$954.9M
Q4 24
$107.6M
$903.0M
Q3 24
$109.7M
$727.3M
Q2 24
$112.4M
$870.5M
Q1 24
$135.2M
$901.4M
Total Debt
COO
COO
SYM
SYM
Q4 25
$2.5B
Q3 25
$2.4B
Q2 25
$2.5B
Q1 25
$2.5B
Q4 24
$2.6B
Q3 24
$2.6B
Q2 24
$2.7B
Q1 24
$2.7B
Stockholders' Equity
COO
COO
SYM
SYM
Q4 25
$8.2B
$663.8M
Q3 25
$8.4B
$221.3M
Q2 25
$8.3B
$210.8M
Q1 25
$8.1B
$205.4M
Q4 24
$8.1B
$196.5M
Q3 24
$7.9B
$197.2M
Q2 24
$7.8B
$418.7M
Q1 24
$7.7B
$417.1M
Total Assets
COO
COO
SYM
SYM
Q4 25
$12.4B
$3.0B
Q3 25
$12.4B
$2.4B
Q2 25
$12.4B
$1.8B
Q1 25
$12.2B
$2.0B
Q4 24
$12.3B
$1.7B
Q3 24
$12.1B
$1.6B
Q2 24
$12.0B
$1.6B
Q1 24
$12.0B
$1.6B
Debt / Equity
COO
COO
SYM
SYM
Q4 25
0.30×
Q3 25
0.29×
Q2 25
0.30×
Q1 25
0.31×
Q4 24
0.32×
Q3 24
0.33×
Q2 24
0.34×
Q1 24
0.35×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
COO
COO
SYM
SYM
Operating Cash FlowLast quarter
$247.9M
$191.5M
Free Cash FlowOCF − Capex
$149.9M
FCF MarginFCF / Revenue
14.1%
Capex IntensityCapex / Revenue
9.2%
Cash ConversionOCF / Net Profit
2.93×
73.61×
TTM Free Cash FlowTrailing 4 quarters
$433.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
COO
COO
SYM
SYM
Q4 25
$247.9M
$191.5M
Q3 25
$261.4M
$530.7M
Q2 25
$96.2M
$-138.3M
Q1 25
$190.6M
$269.6M
Q4 24
$268.1M
$205.0M
Q3 24
$207.5M
$-99.4M
Q2 24
$111.0M
$50.4M
Q1 24
$122.7M
$21.1M
Free Cash Flow
COO
COO
SYM
SYM
Q4 25
$149.9M
Q3 25
$164.5M
Q2 25
$18.1M
Q1 25
$101.2M
Q4 24
$128.1M
$197.7M
Q3 24
$118.5M
$-120.1M
Q2 24
$36.9M
$33.5M
Q1 24
$4.6M
$18.6M
FCF Margin
COO
COO
SYM
SYM
Q4 25
14.1%
Q3 25
15.5%
Q2 25
1.8%
Q1 25
10.5%
Q4 24
12.6%
40.6%
Q3 24
11.8%
-23.9%
Q2 24
3.9%
6.8%
Q1 24
0.5%
4.4%
Capex Intensity
COO
COO
SYM
SYM
Q4 25
9.2%
Q3 25
9.1%
Q2 25
7.8%
Q1 25
9.3%
Q4 24
13.7%
1.5%
Q3 24
8.9%
4.1%
Q2 24
7.9%
3.4%
Q1 24
12.7%
0.6%
Cash Conversion
COO
COO
SYM
SYM
Q4 25
2.93×
73.61×
Q3 25
2.66×
Q2 25
1.10×
Q1 25
1.83×
Q4 24
2.28×
Q3 24
1.98×
Q2 24
1.25×
Q1 24
1.51×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

COO
COO

Sphere Other$365.0M34%
Toric And Multifocal$344.7M32%
Office And Surgical$214.5M20%
Fertility$140.9M13%

SYM
SYM

Systems$590.3M94%
Operation Services$28.8M5%
Software Maintenance And Support$10.9M2%
Revision Of Prior Period Change In Accounting Principle Adjustment$2.9M0%
Related Party$1.1M0%

Related Comparisons